CMS-dependent prognostic impact of KRAS and BRAF(V600E) mutations in primary colorectal cancer

por Smeby, J, Sveen, A, Merok, M A, Danielsen, S A, Eilertsen, I A, Guren, M G, Dienstmann, R, Nesbakken, A, Lothe, R A
Publicado 2018

Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal ca...

por Dienstmann, R, Villacampa, G, Sveen, A, Mason, M J, Niedzwiecki, D, Nesbakken, A, Moreno, V, Warren, R S, Lothe, R A, Guinney, J
Publicado 2019

Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study

por Dienstmann, R., Mason, M. J., Sinicrope, F. A., Phipps, A. I., Tejpar, S., Nesbakken, A., Danielsen, S. A., Sveen, A., Buchanan, D. D., Clendenning, M., Rosty, C., Bot, B., Alberts, S. R., Milburn Jessup, J., Lothe, R. A., Delorenzi, M., Newcomb, P. A., Sargent, D., Guinney, J.
Publicado 2017